Trial Profile
PHASE III COMPARISON OF TAXOTERE (DOCETAXEL) AND TAXOL (PACLITAXEL) IN PATIENTS WITH ADVANCED BREAST CANCER
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Apr 2013
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Aventis Pharmaceuticals
- 09 Apr 2013 New source identified and integrated: ClinicalTrials.gov record.
- 05 Nov 2010 New trial record.